05:52 AM EST, 11/06/2024 (MT Newswires) -- Novo Nordisk ( NVO ) reported Q3 earnings Wednesday of 6.12 Danish kroner ($0.88) per diluted American depositary share, up from 5 kroner a year earlier.

Three analysts polled by Capital IQ expected 5.95 kroner.

Net sales for the quarter ended Sept. 30 were 71.31 billion kroner, compared with 58.73 billion kroner a year earlier.

Analysts polled by Capital IQ expected 71.87 billion kroner.

Novo Nordisk ( NVO ) said it now expects full-year sales growth of 23% to 27% at current exchange rates, from the previous range of 22% to 28%. Analysts polled by Capital IQ expect revenue of 286.62 billion kroner.

Novo Nordisk ( NVO ) shares were up over 4% premarket Wednesday.

Price: 114.91, Change: +4.78, Percent Change: +4.34